BMRN FY 2014 Earnings — BioMarin Pharmaceutical Inc. Revenue & Financial Results | Market Cap Arena

BMRNBioMarin Pharmaceutical Inc.

$12B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$749M+36.6% YoY

Gross Profit

$627M83.7% margin

Operating Income

-$93M-12.4% margin

Net Income

-$134M-17.9% margin

EPS (Diluted)

$-0.92

Cash Flow

Operating Cash Flow

-$74M

Free Cash Flow

-$192M

Stock-Based Comp.

$88M

Balance Sheet

Total Assets

$2.5B

Total Liabilities

$947M

Stockholders' Equity

$1.5B

Cash & Equivalents

$875M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$749M	$548M	+36.6%
Gross Profit	$627M	$460M	+36.3%
Operating Income	-$93M	-$156M	+40.5%
Net Income	-$134M	-$176M	+24.0%